These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15630459)

  • 1. Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.
    Villar LM; Sádaba MC; Roldán E; Masjuan J; González-Porqué P; Villarrubia N; Espiño M; García-Trujillo JA; Bootello A; Alvarez-Cermeño JC
    J Clin Invest; 2005 Jan; 115(1):187-94. PubMed ID: 15630459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis.
    Villar LM; Espiño M; Cavanillas ML; Roldán E; Urcelay E; de la Concha EG; Sádaba MC; Arroyo R; González-Porqué P; Alvarez-Cermeño JC
    Clin Immunol; 2010 Oct; 137(1):51-9. PubMed ID: 20621566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of oligoclonal IgM specificity in multiple sclerosis disease course.
    Villar L; García-Barragán N; Espiño M; Roldán E; Sádaba M; Gómez-Rial J; González-Porqué P; Alvarez-Cermeño J
    Mult Scler; 2008 Mar; 14(2):183-7. PubMed ID: 17942517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of the IgM oligoclonal bands against myelin lipids in multiple sclerosis.
    Ribes García S; Casanova Estruch B; Gómez Pajares F; Juan Blanco MA
    J Neuroimmunol; 2021 Oct; 359():577698. PubMed ID: 34450374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis.
    Brennan KM; Galban-Horcajo F; Rinaldi S; O'Leary CP; Goodyear CS; Kalna G; Arthur A; Elliot C; Barnett S; Linington C; Bennett JL; Owens GP; Willison HJ
    J Neuroimmunol; 2011 Sep; 238(1-2):87-95. PubMed ID: 21872346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment.
    García-Barragán N; Villar LM; Espiño M; Sádaba MC; González-Porqué P; Alvarez-Cermeño JC
    Eur J Neurol; 2009 Mar; 16(3):380-5. PubMed ID: 19175382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?
    Ribes García S; Castillo-Villalba J; Gasque Rubio R; Carratalà Boscà S; Cubas-Nuñez L; Alcalá C; Pérez-Miralles FC; Bonaventura CE
    Mult Scler Relat Disord; 2023 Nov; 79():105033. PubMed ID: 37832257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid oligoclonal IgM test in routine practice: Comparison with quantitative assessment of intrathecal IgM synthesis.
    Zeman D; Kušnierová P; Všianský F; Reguliová K; Škutová M; Woznicová I; Zapletalová O; Hradílek P
    Clin Chim Acta; 2020 Sep; 508():137-145. PubMed ID: 32416174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
    Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM
    Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event.
    Schneider R; Euler B; Rauer S
    Eur J Neurol; 2007 Aug; 14(8):907-11. PubMed ID: 17662013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
    Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
    J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.
    Mandrioli J; Sola P; Bedin R; Gambini M; Merelli E
    J Neurol; 2008 Jul; 255(7):1023-31. PubMed ID: 18535872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal immunoglobulin M synthesis in multiple sclerosis. Relationship with clinical and cerebrospinal fluid parameters.
    Sharief MK; Thompson EJ
    Brain; 1991 Feb; 114 ( Pt 1A)():181-95. PubMed ID: 1998881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
    Jarius S; Lechner C; Wendel EM; Baumann M; Breu M; Schimmel M; Karenfort M; Marina AD; Merkenschlager A; Thiels C; Blaschek A; Salandin M; Leiz S; Leypoldt F; Pschibul A; Hackenberg A; Hahn A; Syrbe S; Strautmanis J; Häusler M; Krieg P; Eisenkölbl A; Stoffels J; Eckenweiler M; Ayzenberg I; Haas J; Höftberger R; Kleiter I; Korporal-Kuhnke M; Ringelstein M; Ruprecht K; Siebert N; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; Rostásy K;
    J Neuroinflammation; 2020 Sep; 17(1):262. PubMed ID: 32883358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation.
    Beltrán E; Obermeier B; Moser M; Coret F; Simó-Castelló M; Boscá I; Pérez-Miralles F; Villar LM; Senel M; Tumani H; Hohlfeld R; Casanova B; Dornmair K
    Brain; 2014 Oct; 137(Pt 10):2703-14. PubMed ID: 25060097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
    Jarius S; Würthwein C; Behrens JR; Wanner J; Haas J; Paul F; Wildemann B
    J Neuroinflammation; 2018 Jan; 15(1):22. PubMed ID: 29347989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis].
    Makshakov GS; Lapin SV; Evdoshenko EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(2 Pt 2):14-20. PubMed ID: 27070356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.
    Álvarez-Cermeño JC; Muñoz-Negrete FJ; Costa-Frossard L; Sainz de la Maza S; Villar LM; Rebolleda G
    J Neurol Sci; 2016 Jan; 360():41-4. PubMed ID: 26723970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome.
    Monreal E; Sainz de la Maza S; Costa-Frossard L; Walo-Delgado P; Zamora J; Fernández-Velasco JI; Villarrubia N; Espiño M; Lourido D; Lapuente P; Toboso I; Álvarez-Cermeño JC; Masjuan J; Villar LM
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.
    Goffette S; Schluep M; Henry H; Duprez T; Sindic CJ
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):308-10. PubMed ID: 14742614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.